Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Merck & Co., Inc.

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRK●NYSE
HealthcareDrug Manufacturers - General
$145.27
$1.97(1.34%)
U.S. Market opens in 0h 10m

Merck & Co., Inc. (MRK)

Meyka AI Score

Z

Key Financials

Market Cap358.4B
P/E Ratio115.16
EPS (TTM)$3.21
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$157.35
3 Months$182.82
1 Year Target$168.33

MRK Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Merck & Co., Inc. (NYSE: MRK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Merck & Co., Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MRK on the NYSE shows an RSI of 49.38, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $168.33 for the NYSE listing.

Key metrics behind Merck & Co., Inc.'s NYSE-traded stock include a P/E ratio of 115.16 and a market capitalization of 358.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MRK on the NYSE.

Price Performance (NYSE: MRK)

1-Day Change
-1.34%
5-Day Change
-1.15%
1-Month Change
-1.90%
3-Month Change
11.34%
6-Month Change
26.74%
Year-to-Date (YTD) Change
38.01%
1-Year Change
66.63%
3-Year Change
40.56%
5-Year Change
77.90%
All-Time (Max) Change
36642.80%

Contact Information

https://www.merck.com
908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

740,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions